Life After ECT: Recovery, Memory, and Preventing Relapse

The first days and weeks

What the end of an ECT course usually feels like

Right after a session, the National Institute of Mental Health lists headaches, upset stomach, muscle aches, memory loss, and disorientation or confusion as the common effects. They cluster around treatment days and taper as the sessions space out and stop.

Because ECT is given under general anesthesia, the treatment day itself is lost to recovery: no driving, no work decisions, and a companion for the trip home. Over a three-times-a-week course that means a stretch of several weeks in which normal routines are interrupted. Many people notice that recent events, appointments, and conversations from the treatment period are hard to recall afterward. That gap is expected; what matters is whether it is tracked and whether it is closing.

Treatment days

Headache, muscle aches, nausea, and confusion for minutes to hours after each session. Plan rides, meals, and rest around every treatment.

The weeks after the course

Memory problems usually improve over days and weeks. Keep a simple log of what is still hard to recall so the team can see the trend.

Months one to six

The highest relapse window. Continuation medication, maintenance ECT if planned, psychotherapy, and scheduled mood checks all belong here.

Six to twelve months

Relapse risk falls but does not vanish. This is when maintenance decisions are reviewed and any persisting memory complaints deserve a formal assessment.

Memory

How memory recovers after ECT, and when it does not

Most memory and thinking problems improve over the days and weeks after the course. The exception that shows up consistently in research is autobiographical memory: recall of personal events from the months around treatment, which can stay patchy.

The largest prospective study of cognition after ECT in ordinary community practice followed 347 patients treated at seven facilities in the New York City area and re-tested them six months after the course. Adverse cognitive effects were still detectable at six months. Two technical choices explained much of the difference between sites: bilateral electrode placement produced more severe and more persistent retrograde amnesia than right unilateral placement, and sine-wave stimulation slowed reaction time both immediately and at six months. Older age, lower pre-treatment intellectual function, and female sex were associated with larger deficits.

That is why the questions about technique belong before the course, not after it. NIMH notes that bilateral placement carries more memory risk than unilateral placement and that brief or ultra-brief pulses reduce cognitive side effects. If you are already past the course, it is still worth knowing which placement and pulse width were used, because that history shapes what to expect and how to interpret a memory complaint at month six.

Patient accounts matter here too. A 2024 narrative analysis of people who experienced long-term adverse effects after ECT in the United Kingdom concluded that “service development is urgently required, especially for ECT follow-up care.” Whatever the average outcome, the person whose memory has not recovered needs an assessment, a name to call, and a plan, not reassurance that most people do fine. Our guide to ECT memory effects covers what to ask about placement, pulse width, and monitoring in more detail.

Relapse

Why the first six months after ECT carry the most risk

A meta-analysis of 32 studies with up to two years of follow-up found that, in modern-era studies of continuation medication, 51.1 percent of people who responded to ECT had relapsed by 12 months, and 37.7 percent had relapsed within the first six months.

Two details from that analysis change how the months after ECT should be planned. First, continuation ECT on its own produced a similar six-month relapse rate, 37.2 percent, so no single follow-up approach removes the risk. Second, in randomized trials, antidepressant medication halved the risk of relapse compared with placebo during the first six months, with a number needed to treat of about three. The strongest evidence base was for tricyclic antidepressants; the authors noted that evidence for newer antidepressants and common augmentation strategies after ECT was limited or absent.

Combining approaches does better than either alone. A 2018 systematic review pooled five randomized trials with 436 patients and found that continuation or maintenance ECT added to medication produced significantly fewer relapses than medication alone at six months (relative risk 0.64) and at one year (relative risk 0.46).

Real-world data point the same way. When ECT capacity was cut in early 2020, a German center followed 53 patients whose maintenance ECT was continued unchanged, reduced in frequency, or discontinued. Over six months, both reduction and discontinuation were associated with significant clinical deterioration, more rehospitalizations, and more new acute ECT courses. The patients at highest risk were those whose original course was most recent.

Continuation care

What continuation and maintenance treatment look like

NIMH describes follow-up treatment, meaning antidepressant medication, maintenance ECT, or both, as usually required to sustain the improvement and reduce the chance that symptoms return. Maintenance ECT can range from one session per week to one session every few months.

Option	What it involves	What the evidence shows	Ask your team
Continuation antidepressant medication	Starting or continuing medication as the acute course ends, with dose and side-effect checks.	Halved six-month relapse versus placebo in randomized trials; strongest data for tricyclics.	Which medication, at what dose, for how long, and who adjusts it?
Continuation or maintenance ECT	Single sessions on a tapering schedule, from weekly to every few months, usually alongside medication.	Added to medication, cut relapse at six and twelve months in pooled trials; stopping or thinning it was followed by deterioration.	What is the schedule, what triggers a change, and how will memory be monitored across sessions?
Psychotherapy and structured monitoring	Scheduled visits, a mood scale such as the PHQ-9, sleep and routine planning, family involvement.	Not isolated in the relapse trials above; it is the layer that catches early change so the other options can be adjusted in time.	How often are mood and memory checked, and what score or sign triggers a call?
No formal plan	Discharge without named follow-up or a written medication plan.	The relapse rates on this page are the baseline this leaves you exposed to.	Who owns follow-up, and when is the first post-ECT appointment?

The right combination depends on how severe the episode was, how many prior episodes there have been, how well medication was tolerated before, and what the memory picture looks like. Those are the same questions that shape the whole treatment-resistant pathway, which is why the treatment-resistant depression hub is the place to look when the after-ECT plan needs a broader rethink.

If symptoms return

Recognizing relapse early, and what the next decision looks like

Relapse after ECT rarely announces itself. It usually shows up as sleep slipping, appetite changing, withdrawal from people, tasks piling up, or the return of a specific thought pattern that was present before the course.

Write down the two or three earliest signs from your previous episode and give the list to one other person.
Use the same mood scale at every check so a rising score is visible before it feels obvious.
Treat a missed maintenance session or a stopped medication as an event to report, not a lapse to hide.
Call early. Reassessment in week two of a relapse is a different conversation from reassessment in month two.

If depression does return, the next step is not automatically another full course of ECT. Depending on your history, the options include a repeat course, continuation or maintenance ECT, medication changes, psychotherapy, TMS, SPRAVATO, or ketamine. Our comparison of TMS, SPRAVATO, and ketamine explains how those three differ in setting, schedule, and evidence, and the ECT overview covers what a repeat course involves.

Dementia and long-term brain health

Does ECT raise the risk of dementia later in life?

The largest study to answer this question found no association. A Danish national cohort followed 168,015 patients with a first hospital diagnosis of an affective disorder for a median of 4.9 years; 5,901 of them received ECT.

In patients under 50 and those aged 50 to 69, ECT was not associated with later dementia compared with age-matched patients who did not receive it. In patients 70 and older, the ECT group had a lower dementia rate, which shrank after propensity-score matching. When competing mortality was taken into account, there was no significant association at any age. The authors concluded that the findings support the continued use of ECT in severe mood episodes, including in older adults. This is population-level evidence; it does not replace an individual assessment when memory has not recovered.

Printable

Your after-ECT plan

Fill this in before the last acute treatment, or at the first follow-up visit, and keep a copy where family can find it.

Date of the last acute treatment, and the placement and pulse width used.
The clinician who owns follow-up, with a phone number and the date of the first post-ECT appointment.
Continuation medication: name, dose, who prescribes it, and the planned duration.
Maintenance ECT schedule, if any, and what would trigger a change to it.
Mood check-in schedule, the scale used, and the score that triggers a call.
Memory check-in: what is still hard to recall, reviewed at one, three, and six months.
The earliest warning signs from the previous episode, in your own words.
Crisis plan: 988, the nearest emergency department, and the treating team’s after-hours number.

Find a program that can own this plan →

Common questions

Life after ECT: questions people ask

What are the long-term effects of ECT?

The best-documented long-term effect is memory. Most memory and confusion problems improve over the days and weeks after the course ends, but a large community study found that adverse cognitive effects, especially gaps in autobiographical memory, were still measurable six months later and were worse after bilateral electrode placement and older sine-wave stimulation. Some people describe lasting memory loss in their own words. Registry data from 168,015 patients did not link ECT to a higher risk of dementia. The other long-term issue is relapse: without continuation treatment, depression often returns within the first year.

How many ECT treatments are needed, and is there a maximum?

A typical acute course is given three times a week and usually reaches its goal within 6 to 12 treatments, according to the National Institute of Mental Health. There is no fixed maximum written into guidelines; the course ends when symptoms have improved or when the team judges that more treatments are not helping. After the acute course, some people continue with maintenance ECT at a much lower frequency, from once a week to once every few months.

What are the side effects of ECT?

Common side effects listed by the National Institute of Mental Health are headaches, upset stomach, muscle aches, memory loss, and disorientation or confusion right after a session. Memory problems usually improve over the days and weeks after the course. Placement and pulse matter: bilateral placement carries more memory risk than unilateral placement, and brief or ultra-brief pulses reduce cognitive side effects.

Does ECT cause dementia later in life?

The largest study to date says no. A Danish national cohort of 168,015 patients with affective disorders, 5,901 of whom received ECT, found no association between ECT and later dementia in patients under 70 after adjustment, and no significant association at any age once competing mortality was taken into account. The authors concluded that the findings support continued use of ECT, including in older adults.

Can depression come back after ECT?

Yes, and this is the central fact of life after ECT. In a meta-analysis of 32 studies, about 51 percent of people who responded to ECT and then took continuation medication had relapsed by 12 months, and most of those relapses happened in the first six months. That is why the plan for the months after ECT matters as much as the course itself.

Can ECT make depression worse?

ECT is one of the most effective treatments for severe depressive episodes, and the studies on this page measure relapse rather than worsening caused by the treatment. What can feel like ECT making things worse is usually one of two things: the early post-treatment period, when confusion and memory gaps are at their peak, or a relapse in the months after the course ends because continuation care was thin or stopped. Both deserve a prompt call to the treating team rather than waiting.

When should ECT be stopped?

The acute course is stopped when symptoms have remitted or plateaued, and that decision belongs to the treating psychiatrist and the patient together. Maintenance ECT is different: a 2021 study of 53 patients whose maintenance ECT was reduced or discontinued during the pandemic found that both changes were followed by significant clinical worsening, more rehospitalizations, and more new acute courses within six months, with the highest risk in people whose index course was recent. Any change to a maintenance schedule should be planned with the team, not made by missing sessions.

What should I do if depression returns after ECT?

Contact the treating team early rather than waiting for the next scheduled visit. The next step is not automatically another full course of ECT. Depending on your history, options include a repeat ECT course, continuation or maintenance ECT, medication changes, psychotherapy, TMS, SPRAVATO, or ketamine. Our treatment-resistant depression hub and our comparison of TMS, SPRAVATO, and ketamine explain how those options differ. If you are thinking about suicide, call or text 988 now.

Sources

What this page is built on

Figures on this page are taken from the abstracts and patient information linked above, accessed September 15, 2026. Relapse rates are study averages and do not predict any one person’s course. This page is educational and does not replace the advice of the treating team.